Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection

References

• Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical applications. Nature Rev Cancer 2002; 2: 342–50
   PubMed Web of Science ®Google Scholar
• Koutsky L, Harper DM. Current findings from prophylactic HPV vaccine trials. Vaccine 2006; 24: S114–21
   Web of Science ®Google Scholar
• Auvinen E, Niemi M, Malm C, Zilliacus R, Trontti A, Fingerroos R, et al. High prevalence of HPV among female students in Finland. Scand J Infect Dis 2005; 37: 873–6
   PubMed Web of Science ®Google Scholar
• Andersson-Ellström A, Dillner J, Hagmar B, Schiller J, Sapp M, Forssman L, et al. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex Transm Dis 1996; 23: 234–8
   PubMed Web of Science ®Google Scholar
• Schiffman M, Castle EP, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890–907
   PubMed Web of Science ®Google Scholar
• Carter JJ, Koutsky LA, Hughes JP, Kuang Lee S, Kuypers J, Kiviat N, et al. Comparison of human papillomavirus type 16, 18 and 6 capsid antibody response following incident infection. J Infect Dis 2000; 181: 1911–9
   PubMed Web of Science ®Google Scholar
• Wang ZH, Kjellberg L, Abdalla H, Wiklund F, Ecklund C, Knekt P, et al. Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids. JID 2000; 181: 456–62
   PubMed Web of Science ®Google Scholar
• af Geijersstam V, Kibur M, Wang Z, Koskela P, Pukkala E, Schiller J, et al. Stability over time of serum antibody levels to human papillomavirus type 16. J Infect Dis 1998; 177: 1710–4
   PubMed Web of Science ®Google Scholar
• International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118: 1481–95.
   PubMed Web of Science ®Google Scholar
• Szarewski A, Maddox P, Royston P, Jarvis M, Anderson M, Guillebaud J, et al. The effects of stopping smoking on cervical Langerhans'cells and lymphocytes. Br J Obstet Gynecol 2001; 108: 295–303
   Google Scholar
• Kataja V, Syrjänen S, Mäntyjärvi R, Yliskoski M, Saarikoski S, Syrjänen K. Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis 1992; 19: 154–60
   PubMed Web of Science ®Google Scholar
• Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of test used to distinguish smokers from non-smokers. Am J Public Health 1987; 77: 1435–8
   PubMed Web of Science ®Google Scholar
• Feyerabend C, Russell MA. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharmacol 1990; 42: 450–2
   Google Scholar
• Knight GJ, Wylie P, Holman MS, Haddow JE. Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies. Clin Chem 1985; 31: 118–21
   PubMed Web of Science ®Google Scholar
• Cummings SR, Richard RJ. Optimum cut-off points for biochemical validation of smoking status. Am J Public Health 1988; 78: 574–5
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Kaasila M, Pasanen K, Toni P, Palmroth J, Laukkanen P, et al. Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s. Int J Cancer 2006; 119: 2612–9
   PubMed Web of Science ®Google Scholar
• Dillner J, Kallings I, Brihmer C, Sikström B, Koskela P, Lehtinen M, et al. Seropositivies to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behaviour. J Infect Dis 1996; 173: 1394–8
   PubMed Web of Science ®Google Scholar
• Kjellberg L, Wang Z, Wiklund F, Edlund K, Ångström T, Lenner P, et al. Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. J Gen Virol 1999; 80: 391–8
   PubMed Web of Science ®Google Scholar
• Syrjänen K, Shabalova I, Petrovichec N, Kozachenko V, Zakharova T, Pajanidi J, et al. Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN. Eur J Epidemiol 2007; 22: 723–35
   PubMed Web of Science ®Google Scholar
• Wiley DJ, Wiesmeier E, Masongsong E, Gylys K, Koutsky L, Ferris DG, and the Proof of Principle Study Investigative Group. Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection. Cancer Epidemiol Biomarkers Prev 2006;15:915–20.
   PubMed Web of Science ®Google Scholar
• Onda T, Carter JJ, Koutsky LA, Hughes JP, Lee S, Kuypers J, et al. Characterization of IgA response among women with incident HPV 16 infection. Virology 2003; 312: 213–21
   PubMed Web of Science ®Google Scholar
• Anderson P, Perderson OF, Bach B, Bonde GJ. Serum antibodies and immunoglobulins in smokers and non-smokers. Cinical Experimental Immunol 1982; 47: 467–73
   PubMed Web of Science ®Google Scholar
• Pagliusi SR, Garland SM. International standard reagents for HPV detection. Dis Markers 2007; 23: 283–96
   PubMed Web of Science ®Google Scholar
• Boffeta P, Clark S, Shen Min, Gislefoss R, Peto R, Anderson A. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 1184–8
   PubMed Web of Science ®Google Scholar
• Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004; 164: 2206–16
   PubMed Web of Science ®Google Scholar
• Simons AM, Mugica van Heckenrode C, Rodriguez JA, Maitland N, Anderson M, Phillips DH, et al. Demonstration of smoking-related DNA damage in cervical epithelium and correlation with human papillomavirus type 16, using exfoliated cervical cells. British Journal of Cancer 1995; 71: 246–9
   PubMed Web of Science ®Google Scholar